Works in Fundamental & Clinical Pharmacology, 2023, Vol 37, Issue 2

Results: 19

Naphazoline and oxymetazoline are superior to epinephrine in enhancing the cutaneous analgesia of lidocaine in rats.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 296, doi. 10.1111/fcp.12853

By:

Chou, An‐Kuo;
Chiu, Chong‐Chi;
Zhu, Guan‐Cheng;
Wang, Jhi‐Joung;
Chen, Yu‐Wen;
Hung, Ching‐Hsia

Publication type:

Article

Ferulic acid improves glucose homeostasis by modulation of key diabetogenic activities and restoration of pancreatic architecture in diabetic rats.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 324, doi. 10.1111/fcp.12860

By:

Salau, Veronica F.;
Erukainure, Ochuko L.;
Olofinsan, Kolawole O.;
Bharuth, Vishal;
Ijomone, Omamuyovwi M.;
Islam, Md. Shahidul

Publication type:

Article

MNK/eIF4E inhibition overcomes anlotinib resistance in non‐small cell lung cancer.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 245, doi. 10.1111/fcp.12850

By:

Zhang, Qi;
Li, Hui;
Li, Quan;
Hu, Qiyan;
Liu, Bo

Publication type:

Article

Differential expression and activities of cytochrome P450 3A in the rat brain microsomes and mitochondria.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 359, doi. 10.1111/fcp.12848

By:

Alshammari, Nouf;
Chandrashekar, Devaraj Venkatapura;
Rashid, Mamunur;
Mehvar, Reza

Publication type:

Article

Survey the effect of drug treatment on modulation of cytokines gene expression in allergic rhinitis.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 340, doi. 10.1111/fcp.12847

By:

Ma, Yan;
Yang, Xiao‐Hong;
Tu, Yi;
Athari, Seyyed Shamsadin

Publication type:

Article

Antioxidant activities of artesunate–procyanidin hybrid compound in erythrocyte and liver of Plasmodium berghei NK65‐infected mice.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 305, doi. 10.1111/fcp.12846

By:

Tijjani, Habibu;
Adebayo, Joseph O.

Publication type:

Article

The effect of diminazene, an angiotensin‐converting enzyme 2 activator, on adenine‐induced chronic kidney disease in rats.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 235, doi. 10.1111/fcp.12845

By:

Abdelrahman, Aly M.;
Ali, Badreldin H.;
Ali, Haytham;
Manoj, Priyadarsini;
Al‐Suleimani, Yousuf

Publication type:

Article

Cell therapy procedure using anti‐inflammatory macrophage M2 can potentially reduce Clinical Score in animals with Experimental Autoimmune Encephalomyelitis: A preclinical systematic review and meta‐analysis study.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 215, doi. 10.1111/fcp.12844

By:

Abdolmaleki, Amir;
Kondori, Bahman Jalali;
Raei, Mehdi;
Ghaleh, Hadi Esmaeili Gouvarchin

Publication type:

Article

Effect of a high‐fat meal on the relative bioavailability of HMPL‐689 in Chinese healthy volunteers.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 385, doi. 10.1111/fcp.12843

By:

Cao, Weie;
Ding, Qichen;
Wang, Yijun;
Liu, Shuyun;
Sun, Shixuan;
Jiang, Fan;
Xu, Xiaoyan;
Sai, Yang;
Wang, Jian;
Chen, Qian;
Liu, Yun

Publication type:

Article

The protective effect of 3‐indolepropanoic acid on aflatoxin B1‐induced systemic perturbation of the liver and kidney function in rats.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 369, doi. 10.1111/fcp.12842

By:

Owumi, Solomon E.;
Arunsi, Uche O.;
Oyelere, Adegboyega K.

Publication type:

Article

Improvement of cognitive dysfunction by a novel phosphodiesterase type 5 inhibitor, Tadalafil.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 263, doi. 10.1111/fcp.12840

By:

Otari, Kishor Vasant;
Patil, Rupesh J.;
Upasani, Chandrashekhar Devidas

Publication type:

Article

Inhibition of kidney potassium channels by fluoxetine: In vivo and in vitro studies.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 226, doi. 10.1111/fcp.12833

By:

Vieira‐Coelho, Maria A.;
Martel, Fátima

Publication type:

Article

Protective assessment of progesterone and its receptor on experimental diabetic neuropathy: Antioxidant and anti‐inflammatory effects.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 287, doi. 10.1111/fcp.12839

By:

Mokhtari, Sanaz;
Sistani Karampour, Neda;
Shams, Mohammad‐Hossein;
Dehpour, Ahmad Reza;
Hasanvand, Amin

Publication type:

Article

Effect of sacubitril/valsartan on cognitive impairment in colchicine‐induced Alzheimer's model in rats.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 275, doi. 10.1111/fcp.12837

By:

Hammadi, Sami H.;
Hassan, Madiha A.;
Allam, Eman A.;
Elsharkawy, Amal M.;
Shams, Sherouk S.

Publication type:

Article

Bupivacaine inhibits the TLR4‐ and TLR2‐Myd88/NF‐κB pathways in human leukocytes.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 347, doi. 10.1111/fcp.12836

By:

Binczak, Marie;
Purenne, Emilien;
Beloeil, Hélène;
Benhamou, Dan;
Mazoit, Jean Xavier

Publication type:

Article

Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 194, doi. 10.1111/fcp.12834

By:

Lin, Chunxiu;
Liu, Peng;
Shi, Chaowen;
Qiu, Lipeng;
Shang, Dongsheng;
Lu, Ziwen;
Tu, Zhigang;
Liu, Hanqing

Publication type:

Article

Photobiological effect of eugenol‐derived 3‐benzoylcoumarin associated with led lights against MDR microorganisms.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 316, doi. 10.1111/fcp.12838

By:

de Sousa, Amanda Karine;
Rocha, Janaina Esmeraldo;
de Freitas, Thiago Sampaio;
Freitas, Priscila Ramos;
Pereira, Raimundo Luiz Silva;
Júnior, Francisco Nascimento Pereira;
Brancaglion, Guilherme Andrade;
de Paulo, Daniela Carvalho;
Carvalho, Diogo Teixeira;
de Menezes, Irwin Rose Alencar;
dos Santos, Francisco Antonio Vieira;
Coutinho, Henrique Douglas Melo;
Júnior, Lucindo José Quintans

Publication type:

Article

Issue Information.

Published in:: Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 191, doi. 10.1111/fcp.12800
Publication type:: Article

Afatinib triggers a Ni<sup>2+</sup>‐resistant Ca<sup>2+</sup> influx pathway in A549 non‐small cell lung cancer cells.

Published in:

Fundamental & Clinical Pharmacology, 2023, v. 37, n. 2, p. 253, doi. 10.1111/fcp.12835

By:

Tsai, Tien‐Yao;
Chen, Cing‐Yu;
Shiao, Lian‐Ru;
Ou, Ting‐Tsz;
Wu, Cheng‐Hsun;
Leung, Yuk‐Man;
Chow, Louis W. C.

Publication type:

Article